Answers are grounded in this paper and cite their sources.
Serious infections with anti-TNF-α therapy were uncommon among tertiary hospitals in Korea; TB was the second most frequent infection. Nevertheless, there were no TB reactivations after anti-TB chemoprophylaxis. Accordingly, physicians should be aware of TB in subjects undergoing anti-TNF-α therapy, especially in countries with a high prevalence of TB.
No takes yet. Share an insight, caveat, or question.
Yoo et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: